December 22, 2004

Get to real reform on RX drug costs

Why is a government task force spending time on analyzing what the cost savings would be from a large-scale commercial system to reimport low-cost Rx drugs from Canada? Is there any surprise in the finding that the cost savings would be negligible?

Senator Byron Dorgan (D-N.D.) said, "I never had much confidence that this study was going to be objective. Millions of Americans obtain prescription medicines from Canada and other countries and do so safely. The federal government itself is buying flu vaccine from abroad right now. The only thing endangered ... is the incrredibly large profits of the drug companies."

Meantime, why must all reform proposals travel the twisted road of Canadian reimportations? Why doesn't the federal government take DIRECT action to negotiate with drug companies?

Posted by schwitz at December 22, 2004 02:51 PM
Comments
StumbleUpon Toolbar Stumble It! StumbleUpon Toolbar Stumble It! StumbleUpon Toolbar Stumble It! StumbleUpon Toolbar Stumble It! StumbleUpon Toolbar Stumble It! StumbleUpon Toolbar Stumble It! StumbleUpon Toolbar Stumble It! StumbleUpon Toolbar Stumble It! StumbleUpon Toolbar Stumble It! StumbleUpon Toolbar Stumble It! StumbleUpon Toolbar Stumble It! StumbleUpon Toolbar Stumble It! StumbleUpon Toolbar Stumble It! StumbleUpon Toolbar Stumble It!
The views and opinions expressed in this page are strictly those of the page author. The contents of this page have not been reviewed or approved by the University of Minnesota.